| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.08 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.08 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |